Check out our most popular compounded medications! Get Started
Loratadine 1%/Betamethasone 0.5% Topical Gel is a compounded medication designed to treat conditions such as Atopic Dermatitis, Psoriasis, Seborrheic Dermatitis, Contact Dermatitis, and Lichen Simplex Chronicus. This semisolid formulation is dispensed through a pump mechanism, allowing for easy and accurate application directly to the affected skin area. The gel-like consistency aids in the targeted treatment and absorption of the active ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Loratadine 1%/Betamethasone 0.5% Topical Gel is a compounded formulation designed to treat a variety of skin conditions. This medication combines the antihistamine properties of loratadine and the anti-inflammatory benefits of the corticosteroid betamethasone. The medication works by reducing inflammation and itching, and can also help to alleviate redness and swelling.
This topical gel is a semisolid formulation that is dispensed through a pump mechanism. This design facilitates easy and precise application on the skin, allowing for targeted treatment and optimal absorption of the active ingredients. The gel-like consistency ensures a smooth application process and enhances the medication's effectiveness.
The Loratadine 1%/Betamethasone 0.5% Topical Gel is typically applied directly to the affected skin area, usually once or twice daily, or as directed by a healthcare professional. It is crucial to follow the instructions provided by your doctor or pharmacist when using this medication. Avoid contact with the eyes, mouth, and other mucous membranes to prevent irritation.
While generally well tolerated, some individuals may experience side effects such as burning, stinging, or irritation at the application site. If you experience any of these or other side effects, it is important to contact your doctor or pharmacist immediately.
If you have any questions or concerns about the Loratadine 1%/Betamethasone 0.5% Topical Gel, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the information and support you need to manage your skin condition effectively.
Loratadine 1%/Betamethasone 0.5% Topical Gel is a semisolid formulation designed for the treatment of mild to moderate atopic dermatitis, contact dermatitis, and seborrheic dermatitis. This medication is dispensed through a pump mechanism, allowing for easy and precise application on the skin for targeted treatment. It is important to note that this formulation should not be used for the treatment of rosacea, acne, or perioral dermatitis.
Patients are advised to apply a thin layer of the gel to the affected area twice daily, or as directed by their healthcare provider. This medication should not be applied to the face, axillae, or groin area. After application, patients should wash their hands thoroughly.
Patients should be monitored for signs of local irritation, such as redness, itching, burning, or stinging. If these symptoms occur, discontinue use and contact your healthcare provider. Avoid contact with the eyes as this may cause irritation. If contact occurs, rinse the eyes with water immediately.
Caution should be exercised when using this medication in combination with other topical medications, as this may increase the risk of local irritation. Similarly, using this medication in combination with other medications may increase the risk of systemic side effects.
Patients should also be cautious when using this medication in combination with alcohol, as this may increase the risk of local irritation. Additionally, using this medication in combination with other products containing loratadine or betamethasone may increase the risk of local irritation or systemic side effects respectively.
If you have any questions about the use of Loratadine 1%/Betamethasone 0.5% Topical Gel, please reach out to your healthcare provider for further guidance.
Loratadine 1%/Betamethasone 0.5% Topical Gel is a compounded formulation designed to treat a variety of skin conditions such as eczema, psoriasis, and dermatitis. This unique combination medication contains Loratadine, an antihistamine that works to alleviate itching and inflammation, and Betamethasone, a corticosteroid that aids in reducing redness and swelling.
The gel is dispensed through a pump mechanism, which allows for easy and precise application directly onto the affected skin area. This targeted treatment facilitates the absorption of the active ingredients in a gel-like consistency, usually applied once or twice a day as per the instructions of your healthcare provider.
When using Loratadine 1%/Betamethasone 0.5% Topical Gel, it is crucial to avoid contact with the eyes, mouth, and other mucous membranes. Additionally, this medication should not be applied on broken or infected skin. If you experience any side effects such as burning, stinging, or irritation, discontinue use and immediately contact your doctor or pharmacist.
It is essential to use Loratadine 1%/Betamethasone 0.5% Topical Gel as directed by your healthcare provider. If you have any questions or concerns about the usage of this medication, do not hesitate to reach out to your healthcare provider for guidance.
Loratadine 1%/Betamethasone 0.5% Topical Gel is a compounded formulation specifically designed for the treatment of various skin conditions. This includes pruritus associated with allergic contact dermatitis, insect bites, and mild to moderate eczema. The combination of loratadine and betamethasone in this formulation provides a synergistic effect, enhancing the efficacy of the treatment.
The gel is dispensed through a pump mechanism, which facilitates easy and precise application on the skin. This targeted treatment allows for optimal absorption of the active ingredients, ensuring that the medication works effectively where it is needed most. The gel-like consistency of the formulation ensures that it is easy to apply and is well tolerated by most patients.
It is important to note that this formulation should not be used for more than two weeks at a time. Prolonged use can lead to skin irritation and thinning. Therefore, it is crucial to follow the prescribed usage instructions to avoid potential side effects. If you have any questions or concerns about the use of this formulation, it is recommended to consult with a healthcare professional.
This is a compounded formulation of two active ingredients, Loratadine and Betamethasone, in a gel form. It is designed to be applied topically on the skin for targeted treatment.
The pump mechanism allows for easy and precise application of the gel on the skin. Simply press down on the pump to dispense the gel.
The gel has a semisolid formulation, which means it is not as liquid as a lotion but not as solid as a cream. This consistency allows for easy application and absorption into the skin.
By applying the gel directly to the affected area, the active ingredients can work directly where they are needed most.
The active ingredients in this gel are Loratadine, an antihistamine used to relieve allergy symptoms, and Betamethasone, a corticosteroid used to reduce inflammation.
The frequency of application will depend on your specific condition and your healthcare provider's instructions. Always follow the prescribed dosage.
This gel is designed for external use only. Avoid contact with eyes, mouth, and other mucous membranes. If you are unsure about where to apply the gel, consult your healthcare provider.
If you experience any side effects such as skin irritation, redness, or swelling, stop using the gel and contact your healthcare provider immediately.
If you are pregnant or breastfeeding, consult your healthcare provider before using this gel. They will be able to advise you on whether it is safe for you to use.
Store this gel at room temperature, away from heat and direct light. Do not freeze. Keep out of the reach of children.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
